Jeffrey Komatz named CFO of Protein Discovery
This article was originally published in Scrip
Executive Summary
The privately held US life sciences company Protein Discovery has named Jeffrey Komatz chief financial officer. He was previously corporate controller at RTI Biologics, and vice-president and corporate controller at Tutogen Medical, which was purchased by RTI in February 2008.